home / stock / grfs / grfs news


GRFS News and Press, Grifols S.A. From 06/29/22

Stock Information

Company Name: Grifols S.A.
Stock Symbol: GRFS
Market: NASDAQ
Website: grifols.com

Menu

GRFS GRFS Quote GRFS Short GRFS News GRFS Articles GRFS Message Board
Get GRFS Alerts

News, Short Squeeze, Breakout and More Instantly...

GRFS - NIO, McCormick & Company, ASE Technology Holding among premarket losers' pack

Agile Therapeutics ( AGRX ) -16% . Bed Bath & Beyond ( BBBY ) -13% on Q1 earnings release . Barnes & Noble Education ( BNED ) -15% on Q4 earnings release . Himax Technologies ( HIMX ) -12% . AeroVironment ( AVAV ) -...

GRFS - Got $20? These 3 Healthcare Stocks Could Be Bargain Buys for 2022 and Beyond

Investors looking for a solid investment in healthcare stocks don't need a bagful of cash. Shares in Takeda Pharmaceutical (NYSE: TAK) , Grifols SA (NASDAQ: GRFS) , and Bayer AG (OTC: BAYR.Y) all trade for $20 or less. Of course, being inexpensive doesn't go hand in ...

GRFS - Deutsche Bank's Depositary Receipts Virtual Investor Conference presentations now available for on-demand viewing

NEW YORK, May 12, 2022 (GLOBE NEWSWIRE) -- Deutsche Bank today announced that the presentations from the May 10 th and 11 th Depositary Receipts Virtual Investor Conference (“dbVIC”) are now available for on-demand viewing. The event featured presentations from interna...

GRFS - Grifols: Long Only

After the results, we are more confident on Grifols' ability to navigate the short-term analyst downgrade. Biotest acquisition completed, now it is time to deliver. Given the strong company track record, we are confident. Too discounted compared to its closest peers. We confirm ou...

GRFS - Grifols stock slumps on Spain's stock exchange paring gains seen after Q1 results

Spanish biotech Grifols (NASDAQ:GRFS) stock fell ~8% May 9 on Spain's stock exchange BME, where it trades under the symbol GRF, giving up most of the gains following its Q1 results on May 6. The company said in its May 6 release that its Q1 revenues grew by mid-to-high single digit, compared ...

GRFS - ChemoCentryx, iRhythm top healthcare gainers; Joint, Endo lead losers' pack

Gainers: ChemoCentryx (CCXI) +19%. iRhythm Technologies (IRTC) +16%. Jounce Therapeutics (JNCE) +15%. Grifols (GRFS) +9%. Sensus Healthcare (SRTS) +8%. Losers: Joint (JYNT) -46%. Endo International (ENDP) -34%. Guardant Health (GH) -26%. Gain ...

GRFS - International companies to host live webcasts at Deutsche Bank's Depositary Receipts Virtual Investor Conference on May 10th and 11th, 2022

NEW YORK, May 05, 2022 (GLOBE NEWSWIRE) -- Deutsche Bank today announced the lineup for its Depositary Receipts Virtual Investor Conference (“dbVIC”) on Tuesday, May 10 and Wednesday, May 11, featuring live webcast presentations from international companies with American Depos...

GRFS - MFGP, API and AQST among pre market gainers

Sonoma Pharmaceuticals SNOA +47% on EPA approval of Nanocyn as hospital-grade disinfectant. Field Trip Health (FTRP) +23%. Harbor Custom Development (HCDI) +18%. Western Digital WDC +12% as activist Elliott calls for separation of flash business. AST SpaceMobile ASTS ...

GRFS - Grifols 2021 Annual Report on Form 20-F filed with the SEC on April 29, 2022

Grifols 2021 Annual Report on Form 20-F filed with the SEC on April 29, 2022 PR Newswire BARCELONA, Spain , April 29, 2022 /PRNewswire/ -- Grifols, S.A. ("Grifols") (MCE: GRF, MCE: GRF.P and NASDAQ: GRFS) announced that it has filed its 2021 Annual Report on Form...

GRFS - Oakmark International Small Cap Fund: Q1 2022 Commentary

We are value investors. In constructing portfolios for our clients, we seek out companies that we believe are trading in the market at significant discounts to their underlying value. These businesses must offer significant profit potential and be run by managers who think and act as owne...

Previous 10 Next 10